Efficacy and safety of cord blood-derived cytokine-induced killer cells in treatment of patients with malignancies

These results demonstrated the feasibility and safety of treating malignancies with CB-CIK cells. The study provides a potential therapeutic approach for the patients with poor health or older patients who cannot tolerate repeated collection of blood.